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Gastric low-grade mucosa-associated lymphoid tissue (low-grade MALT) lymphomas has been associated with Helicobacter pylori (H.
pylori) infection. Although infiltrating T cells with specificity for H. pylori are known to stimulate the development of MALT lymphomas,
the effect of H. pylori eradication on rearranged immunoglobulin heavy chain (IgH) genes of low-grade gastric MALT lymphomas is
unclear. Gastric biopsies from five cases were investigated by cloning and sequence analysis of rearranged IgH genes before and after
the treatment for H. pylori. In all cases, IgH genes were mutated from their germline counterpart. The frequency of intraclonal
sequence heterogeneity before the eradication of H. pylori varied from 0.25 to 0.49%. Clones obtained from the tumours before the
eradication of H. pylori in cases 1 and 2 showed a tendency to display a mutation pattern by positive antigen selection and their
monoclonarity disappeared after the eradication. The frequency of intraclonal sequence heterogeneity of the clones obtained from
cases 3, 4 and 5 (0.12% in case 3, 0.10% in 4 and 0.18% in 5) after the eradication of H. pylori was lower than that in tumours before
the eradication (0.30% in case 3, 0.49% in 4 and not determined in 5). These findings suggest that low-grade gastric MALT
lymphomas expand due to the persistent presence of H. pylori in vivo. The characteristic feature of tumour clones obtained from the
tumours after the eradication of H. pylori is a very low intraclonal heterogeneity, which may potentially be independent of H. pylori.
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In response to antigen stimulation, the reaction of the germinal
centre of lymphoid follicles generates the memory B cells,
producing antibodies with a high affinity and specificity (Maclen-
nan and Gray, 1989; Hentges, 1994). Concerning the somatic
hypermutations in the rearranged immunoglobulins heavy chain
(IgH) variables (VH) gene of the memory B cells, the ration of
replacement (R) to silent (S) mutations in the complementary
determining regions (CDRs) was observed to be higher than that in
the frame work regions (FRs) (Both et al, 1990; Jacob et al, 1991).
Sequence analysis of rearranged VH gene provides information
about the mutation stage of B-cell differentiation and can help
assess the role of antigen stimulation in clonal selection and
expansion (Stewart and Schwartz, 1994). Tumour cells derived
from germinal- to postgerminal-centre B cells such as those of
follicular lymphoma and multiple myeloma have shown extensive
somatic mutations (Bahler and Levy, 1992; Bakkus et al, 1992;
Zelenetz et al, 1992; Sahota et al, 1996). In contrast, tumour cells
from chronic lymphocytic leukaemia and mantle cell lymphoma
have been generally unmutated and are thought to be derived
from pregerminal-centre B cells (Meeker et al, 1988; Zhu et al,
1994).
Ongoing mutation, which indicates an intraclonal sequence
heterogeneity, shows that lymphoma cells continuously react to
antigens in lymphomagenesis (Bakkus et al, 1992; Zelenetz et al,
1992). In mucosa-associated lymphoid tissue (MALT) lymphoma,
frequent and ongoing mutations in the rearranged VH gene have
been reported, providing the evidence of positive antigen selection
during the germinal-centre reaction (Qin et al, 1995; Du et al,
1996). Infection of Helicobacter pylori (H. pylori) plays an
important role in the development of gastric MALT lymphoma
by acting as an indirect antigen stimulation for the H. pylori-
specific T cell implicated in the development of tumours (Hussell
et al, 1993); however, the role of H. pylori eradication in ongoing
mutations in the immunoglobulin VH gene is still unclear.
In this study, we cloned and sequenced CDRs and FRs of
rearranged VH genes before and after the eradication of H. pylori in
gastric MALT lymphomas to determine the role of H. pylori
infection in ongoing mutation in lymphomagenesis.
MATERIALS AND METHODS
Patients
Five cases of primary gastric MALT lymphoma that had undergone
treatment for H. pylori were investigated (Table 1). For the
endoscopic examinations before and after treatment, three to 10
specimens were taken from tumours or suspicious areas for
histology, and two to five others were taken for PCR. The diagnosis
of MALT lymphoma was based on the criteria described by
Isaacson (Isaacson and Norton, 1994) and the WHO classification
(Harris et al, 1999) by staining with haematoxylin and eosin and
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simmunohistochemical examination on paraffin-embedded tissues
from gastric biopsy specimens. The histological findings from the
gastric MALT lymphoma were graded with the histologic scoring
system (Wotherspoon et al, 1993). The surface phenotypes were
analysed by flow cytometry in cases 1, 2 and 5 (Table 1). The H.
pylori status was assessed in eight biopsy specimens as described
previously (Shimizu et al, 1996), and was detected in all cases.
Patients were treated for H. pylori infection for 2 weeks with
lansoprazole (30mgday
 1) and amoxicillin (1500mgday
 1), or
lansoprazole (30mgday
 1), metronidazole (750mgday
 1), and
amoxicillin (1500mgday
 1) or clarithromycin only (600mgday
 1)
(Shimizu et al, 1996). At 6 weeks after treatment (4 weeks after
completion of treatment), the eradication of H. pylori and MALT
lymphoma status was endoscopically assessed. Thereafter, patients
were followed up every 2–6 months. It was found that the
complete eradication of H. pylori had been achieved in all cases.
The patients’ clinical and follow-up data obtained before and
after the treatment for H. pylori are summarised in Table 1.
Cases 1 and 2 had low-grade gastric MALT lymphomas and were
treated for H. pylori, and the eradication of H. pylori was
accompanied by improvement in both the endoscopic and
histological grades.
Case 3 had a low-grade MALT lymphoma with multiple
ulceration in the greater curvature of the gastric corpus. At 9
months after treatment for H. pylori, the endoscopic and
histological findings had not improved. Next, the patient was
given 50mgday
 1 of cyclophosphamide for 7 months, again with
no improvement in the lymphoma. When H. pylori was detected
again, the patient received a second treatment to eradicate the H.
pylori. The treatment was successful and subsequent analysis
showed that the endoscopic findings had improved, but not the
histological grade.
In case 4, diagnosed as low-grade MALT lymphoma, H. pylori
was successfully eradicated but no endoscopic or histological
regression was seen, and 6 months later, the sigmoid colon has also
become involved. Sequence analysis was therefore performed again
at this time.
Case 5 had a 7-year history of recurrent gastric ulcer, and low-
grade MALT lymphoma accompanied by H. pylori infection was
histologically identified. At 28 months after treatment for H. pylori,
the patient was diagnosed as having high-grade components in the
same area as the recurrent ulcer but without H. pylori and
diagnosed with diffuse large B-cell lymphoma (DLBCL). The
clinical stage was stage I, and the patient underwent a total
gastrectomy and splenectomy.
Extraction of DNA from tumour tissue
Gastric biopsy specimens from the tumour areas before treatment
for H. pylori and the areas with residual tumours after the
eradication of H. pylori (available only after treatment for H. pylori
in case 5) were used as a source of tumour DNA for the analysis of
the IgH gene sequence. The Raji B-cell line was used as a
monoclonal control, and normal peripheral blood was used as a
polyclonal control. Genomic DNA was extracted from fresh tissues
using the modified phenol–chloroform extraction procedure
described previously (Sambrook et al, 1989).
Clonal analysis of rearranged IgH gene by PCR
A PCR was performed in a 1605 Air Thermo-Cycler (Idaho
Technology Inc., Idaho Falls, ID, USA). Genomic DNA was
amplified in a final volume of 25ml reaction buffer (50mM Tris-
HCl (pH 8.3), 1.5mM MgCl2, 250mgml
 1 BSA) containing 0.75U of
Taq DNA polymerase (Perkin-Elmer, Norwalk, CT, USA), 200mM
of dNTPs (Idaho Technology), 1mM of an upstream consensus
primer specific for the FR2 of the IgH variable region (V) gene
segments (FR2B: 50-GTCCTGCAGGC[C/T][C/T]CCGG[A/G]AA[A/
G][A/G]GTCTGGAGTGG-30) and a downstream primer specific for
joining region (J) gene segments (ELJH: 50-TGAGGAGACGGT
GACCAGGATCCCTTGGCCCAG-30) (Ramasamy et al, 1992).
Following an initial denaturation step at 941C for 1min and an
initial two cycles of amplification (denaturation at 981C for 15s,
annealing at 601C for 20s, extension step at 721C for 30s), 43
cycles of amplification were performed (denaturation at 981C for
15s, annealing at 601C for 15s, extension step at 721C for 30s),
followed by a final extension step at 721C for 2min. If the reaction
could not be amplified, a seminested PCR was used. For the first
PCR round, amplification was carried out under the same
conditions as described above, except that 28 cycles were
performed instead of 43, with an upstream consensus primer
specific for the FR2 region of V gene segments (FR2A: 50-TGG[A/
G]TCCG[C/A]CAG[G/C]C[T/C][T/C]CNGG-30) (Sambrook et al,
1989) or the FR3 region (FR3A: 50-ACACGGC[C/T][G/C]TGTAT
TACTGT-30) (Brisco et al, 1990; Ramasamy et al, 1992) and a
downstream primer specific for J gene segments (LJH: 50-
TGAGGAGACGGTGACC-30) (Brisco et al, 1990; Ramasamy et al,
1992). For the second round, 1ml of the first-round products was
amplified under the same conditions as described above, except
that 18 cycles were performed instead of 43, with FR2A or FR3A
and VLJH (50-GTGACCAGGGTNCCTTGGCCCCAG-30) (Brisco
et al, 1990; Trainor et al, 1990). To confirm the monoclonal B-
cell proliferation, aliquots of the final reaction products were
subjected to 6% (FR2B-ELJH and FR2A-VLJH products) or 10%
(FR3A-VLJH products) polyacrylamide gel electrophoresis and
were subsequently stained with ethidium bromide.
Cloning and sequencing of IgH genes
The PCR products were electrophoresed through a 3% agarose gel
and were purified with Geneclean II (Bio 101 Inc., Vista, CA, USA).
The purified products were ligated into a pCRtII vector and then
used to transform INVaF0-competent cells according to the
manufacturer’s protocol (Invitrogen, Leek, The Netherlands). Nine
to 12 white colonies were picked at random and were grown
overnight in 2ml of Luria–Bertani medium. When clones were
Table 1 Clinical, histological and laboratorical characteristics of gastric MALT lymphomas





















1 78/F Single ulcer with fold hypertrophy IgM l 5 2 Monoclonal Polyclonal 17
2 65/F Small erosion IgM k 4 2 Monoclonal Polyclonal 10
3 63/F Granular ND 5 5 Monoclonal Monoclonal 6
4 53/M Multiple ulcer ND 5 5 Monoclonal Monoclonal 20
5
a 67/M Single ulcer IgMD l 4 5 ND Monoclonal 30
MALT¼mucosa-associated lymphoid tissue; ND¼not determined.
aAfter eradication of H. pylori.
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sfound to contain an insert of an appropriate size by a restriction
analysis of the plasmid DNA, they were sequenced by the dideoxy
chain termination method using the ABI model 373A DNA
sequencer (Applied Biosystems Inc., Foster, CA, USA) with an
M13 forward primer and an M13 reverse primer.
Sequence analysis
A predominant V sequence with an identical CDR3 was assumed to
be a consensus tumour-derived clone. A sequence alignment
analysis was carried out to compare with current GenBank and V-
BASE sequence directories (MRC Centre for Protein Engineering,
Cambridge, UK) (Cook and Tomlinson, 1995) using MacVector 4.0
sequence analysis software (International Biotechnologies Inc.,
New Haven, CT, USA). The closest germline V genes and their
degree of similarity to each consensus tumour-derived clone were
determined. Mutations in the variable regions were identified by
comparing the consensus sequence of each clone with the closest
published germ line. Two nucleotide exchanges in a single codon
were scored as one replacement mutation. Diversity (D) and J
regions were also determined by their corresponding published
germ line D and J sequences, respectively.
Somatic mutation analysis
To detect positive antigen stimulation, the number of expected
somatic mutations in the rearranged V sequences was calculated
before eradication (cases 1–4) and after eradication (case 5) as
follows. For n random mutations, the number of expected
replacement (R) mutations should equal 0.75n, and the number
of expected silent (S) mutations should equal 0.25n. Without
selection, the R and S mutations should be distributed among the
various V regions according to their respective sizes, that is,
RCDRs¼CDRrel R, RFRS¼FRrel R, SCDRs¼CDRrel S and
SFRs¼FRrel S (CDRrel and FRrel, relative size of CDRs or FRs)
(Bahler and Levy, 1992; Du et al, 1996). The probability (P) that the
observed R mutations in the CDRs were chance occurrences was
calculated by using a binomial mutation model: P¼[n!/
k!(n k!)!]q
k(1 q)
n–k, where k is the number of observed R
mutations in the CDRs and q is the probability that an R mutation
will localise to CDRs (Zelenetz et al, 1992; Chang and Casali, 1994).
Intraclonal sequence heterogeneity was calculated according to the
method of Du et al.
RESULTS
Cloning analysis of rearranged IgH genes by PCR
All four cases (1–4) of low-grade gastric MALT lymphomas were
shown to have a monoclonal pattern before treatment for H. pylori.
After the eradication of H. pylori, identical monoclonal bands
disappeared in cases 1 and 2 but remained in cases 3–5 as shown
in Table 1.
V gene usage
Fresh specimens obtained from cases 1 to 4 before the eradication
of H. pylori were available for VH gene analysis. Sequence analysis
of the IgH gene was also carried out after the eradication of H.
pylori in cases 3–5. Case 1 had two predominant sequences,
suggesting the presence of biclonal tumour-derived clones (cases
1a and b), while cases 4 and 5 showed a single predominant V
sequence with an identical CDR3 sequence. A predominant
sequence from case 2 was identified with only two of 11 clones.
In this case, there appeared to be a minor population of tumour
cells in the biopsy specimens at the posterior wall of the stomach.
In case 3, a tumour-derived sequence was identified with eight of
nine clones. The V genes used by the predominant clones and the
percentage of homology to their closest germline counterpart are
shown in Table 2. The deduced amino-acid sequences of the
predominant clones, as compared with their germline counterpart,
are shown in Figure 1. It was demonstrated that four of five clones
were derived from the V3 family and the remaining one from the
V4 family. The percentage of homology with the germline donor in
cases 1, 3, 4 and 5 varied from 88.2 to 96.4%, whereas in case 2, the
rearranged sequence showed a high degree of homology (98.2%)
(Table 2). No preferential germline donor of V genes was detected
in any of the five cases.
D and J genes segments
Analysis of the J genes showed that all five cases used a J4 gene
segment. No preferential usage of the D segment was observed,
while the probable germline D segments used are shown in Table 2.
Somatic mutation analysis
The number of R mutations in the CDR and FR regions is shown in
Tables 2 and 3. When nucleotide substitutions were attributable to
somatic mutations, these cases had a much higher R-to-S mutation
ratio in the CDRs than the FRs. In all cases, the Ig genes had
mutated from their germline counterpart. The number of expected
R and S mutations was calculated by assuming, in the absence of
selection, that the distribution of R and S mutations among the
various V regions would be in accordance with their respective
sizes. In cases 1–3, the number of R mutations seen in the CDRs
was larger than that could be expected for chance occurrence. In
contrast, there was no significant concentration of R mutations in
the CDRs in cases 4 and 5.
Table 2 Analysis of VH genes from cases of MALT lymphoma before eradication
Mutations
Case GL donor VH family % Homology FR R/S CDR R/S CDR/FR D segment JH segment
1a YAC-9 VH3 93.7 5 0.7 5 45 1 D21/9-DAI or DA4 JH4
1b DP-77 VH3 88.2 8 1.7 8 7 1.3 H23-D-DLR1 JH4
2 DP-77 VH3 98.2 1 412 42 2 H23-D reverse JH4
3 DP-46 VH3 96.4 3 2 3 43 1 DN1 JH4
4 DP-54 VH3 95.4 4 3 2 42 0.5 DXP0lJ H4
5
a V4–31 VH4 92.0 6 2 2 42 0.3 DHQ52 JH4
MALT¼mucosa-associated lymphoid tissue; GL¼germ line. When all mutations induced replacement (S¼0), results are exposed as 4 number of replacements observed.
aAfter eradication of H. pylori.
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sAnalysis of intraclonal sequence heterogeneity
In all of the cases studied, the sequence heterogeneity among the
tumour-derived clones in each case was observed as shown in
Table 4 and Figures 2–6. The frequency of the sequence
heterogeneity in an identical clone varied from 0.25 to 0.49%
before eradication of H. pylori and was found to be 0.18% in case 5,
with none showing any ongoing mutations as shown in Figure 6.
Although two predominant sequences were detected in case 1
before eradication, only case 1a showed intraclonal heterogeneity
as shown in Figure 2. Of the only two tumour-derived sequences
that could be obtained from case 2 before eradication, intraclonal
heterogeneity was observed as shown in Figure 3 and Table 4.
Comparative analysis of B-cell clones before and after the
eradication of H. pylori
Changes in the intraclonal sequence heterogeneity were also
recognised after treatment for H. pylori (Figures 4–6). In cases 3
and 4, intraclonal heterogeneity was observed before and after the
eradication of H. pylori. Before the eradication of H. pylori, in case
3, a total of five mutations were shown in four of eight clones, and
one mutation was shared in two of eight clones as shown in
Figure 4. The sequence heterogeneity was found in three of six
clones from case 4, and two of six clones shared two mutations as
shown in Figure 5. However, after the eradication of H. pylori,
cases 3 and 4 demonstrated only one mutation in one tumour-
derived sequence, and the frequencies of the sequence hetero-
geneity decreased to 0.10 and 0.12%, respectively, indicating that
there was no intraclonal heterogeneity, similar to the finding for
the DLBCL (case 5) as shown in Figure 6.
DISCUSSION
Analyses of the Ig gene in low-grade gastric MALT lymphoma have
demonstrated the presence of somatic hypermutation (Qin et al,
1995) and intraclonal heterogeneity (Du et al, 1996). In the study
presented here, ongoing mutations of rearranged IgH genes were
observed in four gastric MALT lymphomas before the eradication
of H. pylori. These results suggest that gastric low-grade MALT
lymphomas derive from hypermutated postgerminal-centre mem-
ory B cells, which have undergone antigen selection as described
by Qin et al and Du et al. In our study, intraclonal sequence
heterogeneities of the IgH genes remained even after the
eradication in three cases with lower frequencies than before the
eradication of H. pylori. These findings suggest that there may be
an ongoing mutation independent of H. pylori infection or clonal














Figure 1 Deduced amino-acid sequence of the V regions. Comparisons are made with the closest germline genes. Upper case letters, replacement
mutations; lower case letters, silent mutations. The sequences of the PCR primers of FR2A or FR2B have been excluded.
Table 3 Distribution of mutations in the tumour-derived VH sequences
Expected Observed
Case Region R S R S P
a
1a CDR 2 1 5 0
0.04
FR 5 2 2 3
1b CDR 4 1 7 1
0.02
FR 8 3 5 3
2C D R 0 0 2 0
0.10
FR 2 1 1 0
3C D R 2 0 3 0
0.09
FR 3 1 2 1
4C D R 2 0 2 0
0.27
FR 3 1 3 1
5C D R 2 0 2 0
0.30
FR 4 2 4 2
aP is the probability of obtaining the number of R mutations found in the CDR by
chance.
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sintraclonal sequence heterogeneities of IgH genes of gastric MALT
lymphoma before and after the eradication of H. pylori may hold to
a clue for further understanding of the characteristics of the
development and progression of this kind of MALT lymphoma.
As for the recombination of Ig genes, the fact that the
accumulation of somatic mutations shows a much higher
replacement (R)/silent (S) ratios in the CDRs than the FRs in the
V genes indicates that the B cell has undergone positive antigen
selection during the germinal-centre reaction (Stewart and
Schwartz, 1994). Assessment of the pattern of the IgH mutations
responsible for H. pylori in MALT lymphoma determined that all
of our cases of gastric MALT lymphoma displayed a hypermuta-
tion mechanism, as also previously reported (Qin et al, 1995; Du
et al, 1996). Furthermore, the disappearance pf monoclonarity in
the clones from cases 1 and 2 after the eradication of H. pylori
indicated a tendency to display a mutation pattern by positive
antigen selection, because the number of R mutations was higher
in the CDRs than could be expected by chance, especially in case 1
Table 4 Frequency of intraclonal sequence heterogeneity before and after treatment for H. pylori










1a 5/11 0.37 — —
1b 5/11 0.00 — —
2 2/11 0.25 — —
3 8/9 0.30 4/6 0.12
4 6/6 0.49 6/6 0.10






















Figure 2 Intraclonal heterogeneity of the nucleotide sequences of the V genes used by one of two predominant tumour clones from case 1. Case1a-1
through case1a-5 represents individual cloned sequences that are compared with the closest gene, YAC-9. Silent or replacement mutations are indicated












Figure 3 Intraclonal heterogeneity of the nucleotide sequences of the V genes from case 2. Case 2-1 through case 2-2 represents individual cloned
sequences that are compared with the closest gene, DP-77. Silent or replacement mutations are indicated below the sequences, in lower case or upper case
letters, respectively. The sequences of the PCR primers (both FR2A and VLJH) have been excluded.
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s(Po0.05). In addition to the frequency of hypermutation of IgH
genes, the mutation pattern of positive selection may also reflect
the development of MALT lymphoma status dependent on H.
pylori. As for V gene usage, the lymphoma cells in four of the five
cases used V3 genes, and the remaining one used a V4 family gene.
With the exception of case 2, the percentages of homology to their
closest germline counterparts are varied, so that there was no
preferential usage of the V gene could be observed.
In cases 3–5, low intraclonal heterogeneity of the IgH genes in
residual clones after the eradication of H. pylori was low, which
seems to imply the expansion of an independent tumour clone on
H. pylori. Although complete eradication of H. pylori was achieved
without relapse, in case 1 with the biclonal tumour-derived clone,
case 1b had no intraclonal sequence heterogeneity before
treatment, so it is conceivable that an expansion had already
occurred. In case 4, tumour cells were treated with cyclopho-
sphamide before the second analysis of IgH gene, so that the
treatment may have affected the low intraclonal heterogeneities.
Case 5 had a high-grade component and karyotypic abnormality in
the form of trisomy 3 (data not shown) and was considered to
consist of the transformed DLBCL tumour cell clones. The
equivalent of the remaining low intraclonal heterogeneities is still
unclear and warrants further investigation.
In conclusion, low-grade gastric MALT lymphomas seem to
expand in vivo due to an ongoing mutator of H. pylori in vivo. The
characteristic feature of tumour clones obtained from residual
tumours after the eradication of H. pylori seems to be a very low
intraclonal heterogeneity, which may potentially be independent of
H. pylori. This characteristic feature of these clones need to be
considered as an important factor in the clinical management of
patients with gastric MALT lymphomas.
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Figure 4 Intraclonal heterogeneity of the nucleotide sequences of the V genes from case 3 before and after the eradication of H. pylori. Case 3B: before
eradication; case 3A: after eradication. Case 3B-1 through case 3A-8 represents individual cloned sequences that are compared with the closest gene, DP-
46. Silent or replacement mutations are indicated below the sequences, in lower case or upper case letters, respectively. The sequences of the PCR primers
(both FR2A and VLJH) have been excluded.
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Figure 5 Intraclonal heterogeneity of the nucleotide sequences of the V genes from case 4 before and after the eradication of H. pylori. Case 4B: before
eradication; case 4A: after eradication. Case 4B-1 through case 4A-6 represents individual cloned sequences that are compared with the closest gene, DP-
54. Silent or replacement mutations are indicated below the sequences, in lower case or upper case letters, respectively. The sequences of the PCR primers

























Figure 6 Intraclonal heterogeneity of the nucleotide sequences of the V genes from case 5. Case 5-1 through case 5-10 represents individual cloned
sequences that are compared with the closest gene, V4–31. Silent or replacement mutations are indicated below the sequences, in lower case or upper
case letters, respectively. The sequences of the PCR primers (both FR2B and ELJH) have been excluded.
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